Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Completed Phase 1 Trials for Dasatinib (DB01254)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028499 (Recurrent Adult Diffuse Small Cleaved Cell Lymphoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00608361 | Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery | Treatment |